ProPSA and diagnostic biopsy tissue DNA content combination improves accuracy to predict need for prostate cancer treatment among men enrolled in an active surveillance program.
Abstract
No abstract available.
Authors
- Carter HB
- Epstein JI
- Isharwal S
- Landis P
- Makarov DV
- Marlow C
- Partin AW
- Sokoll LJ
- Veltri RW